Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001186323 | SCV001352712 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-01-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001481252 | SCV001685591 | likely benign | BAP1-related tumor predisposition syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001186323 | SCV002670749 | likely benign | Hereditary cancer-predisposing syndrome | 2024-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV001481252 | SCV005404864 | likely benign | BAP1-related tumor predisposition syndrome | 2024-07-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |